Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             265 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 1006 A Compound From a European Medicinal Plant Induces Different Anti-cancer Effects in Various Cancer Cells Bour, T.
 2012
 48 Supplement 6 p. S243-
1 p.
 artikel
2 1162 A Comprehensive Analysis of Circadian Gene Polymorphisms, Night Work and Breast Cancer Risk Zienolddiny, S.
 2012
 48 Supplement 6 p. S279-S280
2 p.
 artikel
3 989 Acquired Resistance to Aromatase Inhibitors is Paired With Hyper-activation of Akt/mTor Pathway in New Cellular Models of Hormone-dependent Breast Cancer Vilquin, P.
 2012
 48 Supplement 6 p. S239-
1 p.
 artikel
4 1026 AF1q – a Novel Mediator of Basal and 4-HPR-Induced Apoptosis in Ovarian Cancer Cells Appierto, V.
 2012
 48 Supplement 6 p. S247-S248
2 p.
 artikel
5 582 ALK Rearrangement and EGFR Copy Number Gains/mutations in Czech Non-small Cell Lung Cancer Patients Koudelakova, V.
 2012
 48 Supplement 6 p. S139-
1 p.
 artikel
6 A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer Ferrarotto, Renata
 2012
 48 Supplement 6 p. 820-826
7 p.
 artikel
7 715 A Multi-marker Approach for Early Detection of HBV-related Hepatocellular Carcinoma in Areas of High Incidence da Costa, A. Nogueira
 2012
 48 Supplement 6 p. S169-S170
2 p.
 artikel
8 321 Analysis of Combinatorial Effect of Multikinase Inhibitor (Sorafenib, Sunitinib) or Cetuximab with MEK or mTOR Inhibitors in Human Head and Neck Cancer Cells Byeon, H.
 2012
 48 Supplement 6 p. 98-
1 p.
 artikel
9 537 Analysis of the Codon 72 Polymorphism of P53 Gene in Patients With Multinodular Goiter to Develop Thyroid Cancer Bayram, B.
 2012
 48 Supplement 6 p. S127-
1 p.
 artikel
10 779 Androgen Receptor Phosphorylation is Associated With Clinical Outcome Measures in Hormone Naive Prostate Cancer McCall, P.
 2012
 48 Supplement 6 p. S186-
1 p.
 artikel
11 681 Aneuploidy Facilitates Oncogenic Transformation Via Specific Genetic Alterations Hognas, G.
 2012
 48 Supplement 6 p. S161-
1 p.
 artikel
12 287 An HMGA1 Specific Transcriptional Program Promotes Metastasis in Breast Cancer Pegoraro, S.
 2012
 48 Supplement 6 p. S70-
1 p.
 artikel
13 An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancer Powles, Thomas
 2012
 48 Supplement 6 p. 3171-3176
6 p.
 artikel
14 64 An Innovation in Breast Cancer Care in Ottawa, Canada: the Evaluation and Validation of a Rapid Diagnostic and Support Clinic for Women Assessment for Breast Cancer Arnaout, A.
 2012
 48 Supplement 6 p. S59-
1 p.
 artikel
15 1129 An in Vivo Evaluation of the Potential of 188Re-PEI-MP for Therapy of Bladder Carcinoma and 99mTc-PEI-MP for Diagnosis and Follow Up Ferreira, S.
 2012
 48 Supplement 6 p. S272-
1 p.
 artikel
16 355 A Novel Highly Potent AKT Inhibitor TAS-117 Demonstrated Synergistic Antitumor Activity in Combination with Paclitaxel Through Enhancement of Apoptosis Induction Ichikawa, K.
 2012
 48 Supplement 6 p. 108-
1 p.
 artikel
17 266 A Novel Rapid and Accurate Lung Cancer Diagnostic Method Using Fluorescent Bacteria Zhu, Y.
 2012
 48 Supplement 6 p. 82-
1 p.
 artikel
18 605 A Novel Technique for Lumpectomy Margin Assessment: a Cost-effectiveness Analysis Alvarado, M.
 2012
 48 Supplement 6 p. S221-
1 p.
 artikel
19 153 Anthropometric Breast Measurement – a Study of 55 Korean Female Kim, M.j.
 2012
 48 Supplement 6 p. S84-
1 p.
 artikel
20 307 Anti-tumor Activities of Lenvatinib Against RET Gene Fusion Driven Tumor Models Okamoto, K.
 2012
 48 Supplement 6 p. 94-
1 p.
 artikel
21 562 Antitumor Activity of the Polo-like Kinase (PLK) Inhibitor, TAK-960, Alone and in Combination with Standard Agents Against KRAS WT and MT Colorectal Cancer (CRC) Models Pitts, T.
 2012
 48 Supplement 6 p. 172-173
2 p.
 artikel
22 AOS15 Assessment of cognitive function in patients with breast and colon cancers undergoing chemotherapy: Results from an exploratory pilot study Poovaneswaran, S.
 2012
 48 Supplement 6 p. S9-
1 p.
 artikel
23 AOS4 Detection of human papillomavirus DNA in patients with different cervical lesions in Kurdistan region, Iraq Ali, K.S.
 2012
 48 Supplement 6 p. S4-S5
2 p.
 artikel
24 AOS12 Efficacy and safety of trabectedin versus gemcitabine/docetaxel in patients with sarcoma after failure of anthracycline and/or ifosfamide Adam, K.
 2012
 48 Supplement 6 p. S7-S8
2 p.
 artikel
25 AOS28 High pathological response rate with docetaxel plus cisplatin plus fluorouracil induction regimen in oesophageal cancer: Initial experience Noronha, V.
 2012
 48 Supplement 6 p. S13-
1 p.
 artikel
26 AOSOP2 Association of caveolin-1 genotypes with susceptibility to oral cancer in Taiwan Tsai, C.
 2012
 48 Supplement 6 p. S1-
1 p.
 artikel
27 AOSOP3 Combination of bevacizumab and erlotinib in the treatment of patients with advanced hepatocellular carcinoma with sorafenib-refractory disease: Results of a pilot phase II study Yau, T.
 2012
 48 Supplement 6 p. S1-S2
2 p.
 artikel
28 AOS2 Prevalence of symptomatic deep vein thrombosis in patients with cancer admitted to the National Kidney and Transplant Institute in the Philippines Apostol, A.S.
 2012
 48 Supplement 6 p. S4-
1 p.
 artikel
29 AOS11 Trabectedin in sarcoma: Initial experience in the Asian setting Adam, K.
 2012
 48 Supplement 6 p. S7-
1 p.
 artikel
30 A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks O’Brien, M.E.R.
 2012
 48 Supplement 6 p. 68-74
7 p.
 artikel
31 376 Apoptotic Intrinsic Pathway as an Essential Key for the Human Salivary Gland Branching Morphogenesis Teshima, T.H.N.
 2012
 48 Supplement 6 p. S91-
1 p.
 artikel
32 Appropriate end-points for right results in the age of antiangiogenic agents: Future options for phase II trials in patients with recurrent glioblastoma Brandes, A.A.
 2012
 48 Supplement 6 p. 896-903
8 p.
 artikel
33 A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01) Ji, Jun Ho
 2012
 48 Supplement 6 p. 3198-3204
7 p.
 artikel
34 A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas Cesne, Axel Le
 2012
 48 Supplement 6 p. 3036-3044
9 p.
 artikel
35 652 A Role for ERK Signaling in Regulation of Promoter Activity of the mPttg1 Locus in BTC3 Insulinoma Cells Font, L. Manyes i
 2012
 48 Supplement 6 p. S154-
1 p.
 artikel
36 118 2-arylamino-6-ethynylpurines as Potent Irreversible Inhibitors of the Mitotic Kinase Nek2 Carbain, B.
 2012
 48 Supplement 6 p. 37-
1 p.
 artikel
37 620 A Study of PNT2258 (DNA-targeted Blocker of BCL2 Expression) in Patients with Advanced Solid Tumors Rasco, D.W.
 2012
 48 Supplement 6 p. 191-
1 p.
 artikel
38 499 Atypical Ductal Hyperplasia at Surgical Resection Margins do not Increase the Risk of Recurrence in Invasive Breast Cancer Patients Shin, H.C.
 2012
 48 Supplement 6 p. S192-
1 p.
 artikel
39 Author Index 2012
 48 Supplement 6 p. S227-S242
16 p.
 artikel
40 904 Biological Mechanism of Action of Novel −3−(2,5-diphenylfuran-3-yl)−4-methoxy-1H-indole in Human Leukemic Cell Lines Kumar, D.
 2012
 48 Supplement 6 p. S219-
1 p.
 artikel
41 830 Bi-phasic Profile of MnSOD During Tumor Progression in Prostate Cancer Cuervo, A. Miar
 2012
 48 Supplement 6 p. S199-
1 p.
 artikel
42 97 Birinapant, a Novel Smac Mimetic, Activates Apoptosis in NF-kappaB-dependent Gynecologic Cancer Cell Lines Noonan, A.M.
 2012
 48 Supplement 6 p. 31-
1 p.
 artikel
43 765 Blinded, Independent, Central Image Review in Oncology Trials –Will the Study Endpoint Impact the Adjudication Rate or Will the Adjudication Rate Impact the Study Endpoint? Urbank, A.
 2012
 48 Supplement 6 p. S181-
1 p.
 artikel
44 Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up study den Heijer, Mariska
 2012
 48 Supplement 6 p. 1263-1268
6 p.
 artikel
45 Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial Kim, Seok Jin
 2012
 48 Supplement 6 p. 3223-3231
9 p.
 artikel
46 181 Breast Carcinoma in Mexican Women, Molecular Subtypes Using Immunohistochemical Surrogate Markers Sánchez, V. Perez
 2012
 48 Supplement 6 p. S92-
1 p.
 artikel
47 531 Calcium Channel Transient Receptor Potential V6 (TRPV6) as a Potential Therapeutic Target for Some Breast Cancers Peters, A.A.
 2012
 48 Supplement 6 p. 163-164
2 p.
 artikel
48 23 Cancer Survivorship: NCI research and insights into this new and growing area Rowland, J.
 2012
 48 Supplement 6 p. S47-
1 p.
 artikel
49 423 Can Surgery Be Avoided in Patients with Breast Cancer Who Achieve a Complete Clinical Response to Neoadjuvant Chemotherapy? Makris, A.
 2012
 48 Supplement 6 p. S170-
1 p.
 artikel
50 392 Can the Day 8 Blood Test Be Omitted for Patients Receiving Oral Vinorelbine for Metastatic Breast Cancer? Thomas, R.
 2012
 48 Supplement 6 p. S157-
1 p.
 artikel
51 341 Carcinoma Associated Fibroblasts Provide a Niche for Cancer Stem Cells – Analysis of a New Cell Culture Model in Urothelial Cancer Hatina, J.
 2012
 48 Supplement 6 p. S83-
1 p.
 artikel
52 338 CC-223, a Selective mTOR Kinase Inhibitor, Potently Inhibits Proliferation of a Large Panel of Cancer Cell Lines in Vitro Xu, S.
 2012
 48 Supplement 6 p. 103-
1 p.
 artikel
53 445 CD157 is a Novel Prognostic Marker of Malignant Pleural Mesothelioma Involved in the Control of Tumor Aggressiveness Giacomino, A.
 2012
 48 Supplement 6 p. S107-
1 p.
 artikel
54 49 Champions TumorGraft Models Represent Oncology Clinical Trial Populations Hewit, T.H.
 2012
 48 Supplement 6 p. 17-
1 p.
 artikel
55 288 Changes in Estrogen Receptor (ER), Progesterone Receptor (PgR) and HER2/neu Status During Primary Systemic Chemotherapy in Breast Cancer Tozuka, K.
 2012
 48 Supplement 6 p. S126-S127
2 p.
 artikel
56 614 Characterization of Oncogenesis Process of Sporadic and Familial Epithelial Ovarian Cancer (EOC) Kamieniak, M.M.
 2012
 48 Supplement 6 p. S146-S147
2 p.
 artikel
57 534 CHEK1 Cooperates with IKKe to Promote Survival of Ovarian Cancer Patients Kim, M.
 2012
 48 Supplement 6 p. 164-
1 p.
 artikel
58 Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival Buglione, Michela
 2012
 48 Supplement 6 p. 3019-3026
8 p.
 artikel
59 410 Circumventing Paradoxical Drug-induced Activation of the MAPK Pathway with Next Generation B-RAF V600E Inhibitors Vernier, J.M.
 2012
 48 Supplement 6 p. 125-
1 p.
 artikel
60 Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial Gross-Goupil, M.
 2012
 48 Supplement 6 p. 721-727
7 p.
 artikel
61 Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function Morales-Barrera, Rafael
 2012
 48 Supplement 6 p. 1816-1821
6 p.
 artikel
62 08 Colorectal cancer in elderly patients: A single-center experience Bensalem, A.
 2012
 48 Supplement 6 p. S15-
1 p.
 artikel
63 169 Combination of Selective ALK Inhibitor ASP3026 with Inhibition of IGF-1R Signaling Overcomes Crizotinib Resistance in NCI-H2228 Human NSCLC Cells Ueno, Y.
 2012
 48 Supplement 6 p. 52-
1 p.
 artikel
64 733 Common Breast Cancer Susceptibility Alleles in BRCA-positive and BRCA-negative Male Breast Cancer Silvestri, V.
 2012
 48 Supplement 6 p. S174-
1 p.
 artikel
65 1148 Comparative MicroRNA Expression Profiles in Human Cervical Cancer Gocze, K.
 2012
 48 Supplement 6 p. S276-
1 p.
 artikel
66 409 Concordance of St. Gallen Intrinsic Subtypes in Core Biopsies and Related Surgical Specimens of Breast Cancer Focke, C.
 2012
 48 Supplement 6 p. S165-
1 p.
 artikel
67 1181 Content Validity of the Sexual Concerns Questionnaire-Gynecological Cancer Abbott Anderson, K.
 2012
 48 Supplement 6 p. S284-
1 p.
 artikel
68 95 Correlating Breast Density Measured by MRI and Diffuse Optical Spectroscopic Imaging During Neoadjuvant Chemotherapy Leproux, A.
 2012
 48 Supplement 6 p. S68-S69
2 p.
 artikel
69 274 Correlation of CD10 and EGFR Expression in Phyllodes Tumors of the Breast Kim, J.
 2012
 48 Supplement 6 p. S122-S123
2 p.
 artikel
70 303 Could the Axilla Be Managed Less Aggressively in Selected Node-positive Breast Cancer Patients? Walker, G.A.
 2012
 48 Supplement 6 p. S130-S131
2 p.
 artikel
71 1080 Dacarbazine-mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Prevents Melanoma Growth Mignot, G.
 2012
 48 Supplement 6 p. S260-
1 p.
 artikel
72 619 Deciphering Non-BRCA1/2 Familial Breast Tumor Heterogeneity by MiRNA Expression Profiling Tanic, M.
 2012
 48 Supplement 6 p. S147-
1 p.
 artikel
73 136 Delays in Time to Treatment in Breast Cancer; Does It Really Have an Impact on Overall/Disease Free Survival? Shandiz, F. Homaei
 2012
 48 Supplement 6 p. S80-
1 p.
 artikel
74 364 Depression Associated with Goserelin in Premenopausal Breast Cancer Patients – Preliminary Study Kim, J.
 2012
 48 Supplement 6 p. S149-
1 p.
 artikel
75 124 Designer Hyper Interleukin 11 (H11) is a Molecule of Great Potential for Treatment of Thrombocytopenia Dams-Kozlowska, H.
 2012
 48 Supplement 6 p. 39-
1 p.
 artikel
76 257 Design of RESILIENCE: a Phase 3 TRial Comparing CapecitabinE in Combination with SorafenIb or PLacebo for Treatment of Locally Advanced or MetastatIc HER2-Negative Breast CancEr Baselga, J.
 2012
 48 Supplement 6 p. S117-
1 p.
 artikel
77 Determinants of successful implementation of population-based cancer screening programmes Lynge, Elsebeth
 2012
 48 Supplement 6 p. 743-748
6 p.
 artikel
78 475 Determination of HER2 Gene Status and Chromosome 17 Polysomy in Penile Carcinoma and Association With HER2 Protein Levels Silva, A.M.T.
 2012
 48 Supplement 6 p. S114-S115
2 p.
 artikel
79 979 Development of a Trans-kingdom Expression System in Cancer Therapy Shi, L.
 2012
 48 Supplement 6 p. S236-
1 p.
 artikel
80 557 Development of New Generation of Breast Implant Using Silsesquioxane Nanocomposites Shell Mousavi, L.
 2012
 48 Supplement 6 p. S208-
1 p.
 artikel
81 Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009–2010: The AnemOnHe study Spielmann, Marc
 2012
 48 Supplement 6 p. 101-107
7 p.
 artikel
82 475 Differences in Gene Expression Between Androgen Receptor Positive and Negative Triple Negative (ER/PR/Her2) Breast Carcinomas Ghazalpour, A.
 2012
 48 Supplement 6 p. 147-
1 p.
 artikel
83 109 Digital Mammography Screening – Evidence of Incremental Breast Cancer Detection by Bilateral Ultrasound at Assessment Biesheuvel, C.
 2012
 48 Supplement 6 p. S72-
1 p.
 artikel
84 444 DNA Methylation-Based as a Prediction of Therapeutic Outcome in Serum of Patients with Breast Cancer Martinez-Galan, J.
 2012
 48 Supplement 6 p. 138-
1 p.
 artikel
85 Do discordant cancers share familial susceptibility? Hemminki, Kari
 2012
 48 Supplement 6 p. 1200-1207
8 p.
 artikel
86 240 Does ‘PDO’ Deserve T4b Status in Early Breast Cancer? Jha, D.
 2012
 48 Supplement 6 p. S112-
1 p.
 artikel
87 78 Doppler Ultrasound Scoring to Predict Chemotherapeutic Response in Advanced Breast Cancer Srivastava, V.
 2012
 48 Supplement 6 p. S63-
1 p.
 artikel
88 554 Do Screen-detected Breast Cancers Have Free Margins More Often Than Symptomatic Breast Cancers? de Munck, L.
 2012
 48 Supplement 6 p. S207-
1 p.
 artikel
89 922 DRAGO, a P53/p73 Regulated Gene That Modulates Survival in Tumour Prone Mouse Model Rusconi, P.
 2012
 48 Supplement 6 p. S223-
1 p.
 artikel
90 52 Dual Bioluminescence/Fluorescence Imaging of Hollow Fibres in Living Animals Papadopoulou, N.
 2012
 48 Supplement 6 p. 18-
1 p.
 artikel
91 E6. Can an international consensus meeting change the future of advanced breast cancer patients? Highlights from ABC1 Consensus Meeting Cardoso, Fatima
 2012
 48 Supplement 6 p. S13-S14
2 p.
 artikel
92 297 Effectiveness of Acute Cycling of Supraphysiologic Testosterone Given Together with Etoposide in Men with Castration Resistant Prostate Cancer Denmeade, S.
 2012
 48 Supplement 6 p. 91-
1 p.
 artikel
93 177 Effect of Androgens on the Expression of Ca2+-binding Protein, Regucalcin, and Ca2+-channels in MCF-7 Cells Marques, R.
 2012
 48 Supplement 6 p. S43-
1 p.
 artikel
94 Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009 Dikken, Johan L.
 2012
 48 Supplement 6 p. 1004-1013
10 p.
 artikel
95 369 Effects of the Specific PI3K Inhibitor BKM120, the Dual PI3K/mTOR Inhibitor BEZ235, and Specific mTOR Inhibitors Everolimus and Temsirolimus in Renal and Hepatic Carcinoma Models Resistant to Sunitinib and Sorafenib Serova, M.
 2012
 48 Supplement 6 p. 113-
1 p.
 artikel
96 34 Efficacy of VEGFR2 Targeted mAb Therapy in Preclinical Colorectal Cancer Model Resistant to Anti-VEGF mAb Therapy Surguladze, D.
 2012
 48 Supplement 6 p. 13-
1 p.
 artikel
97 Embryonal cancers in Europe Gatta, Gemma
 2012
 48 Supplement 6 p. 1425-1433
9 p.
 artikel
98 110 EMT Followed in Three Dimensions in Vitro Cygan, P.A.
 2012
 48 Supplement 6 p. S27-
1 p.
 artikel
99 6 Enrichment Strategies for Patient Selection in Early Oncology Trials – a Missed Opportunity, a Must or a way to Focus on the Wrong Target? Soria, J.
 2012
 48 Supplement 6 p. 4-
1 p.
 artikel
100 489 Enzastaurin (LY317615.HCl) and Its Primary Metabolite (LY326020.HCl) Exert Antitumor Effects in Diffuse Large B Cell Lymphoma Through Multiple Mechanisms, Most Notably Control of 4EBP1 Activity Graff, J.
 2012
 48 Supplement 6 p. 151-152
2 p.
 artikel
101 E9. Oncoplastic Surgery: increasing surgical options for breast cancer patients Rubio, Isabel T.
 2012
 48 Supplement 6 p. S20-S21
2 p.
 artikel
102 701 Escherichia Coli and Colorectal Carcinogenesis Bonnet, M.
 2012
 48 Supplement 6 p. S166-
1 p.
 artikel
103 796 Establishment of Primary Endometrial Carcinoma Cell Cultures as a Preclinical Tool for Drug Screening – Methods and Characterization Schrauwen, S.
 2012
 48 Supplement 6 p. S189-S190
2 p.
 artikel
104 421 Ethanol Directly Modulates Reactive Oxygen Species Generation in Oral Squamous Cell Carcinoma Cell Lines O'Callaghan, K.
 2012
 48 Supplement 6 p. S102-
1 p.
 artikel
105 623 Evaluating the Potential of OXi4503 to Enhance Tumour Response to Radiation Administered in Clinically Relevant Conventional or Stereotactic Schedules Horsman, M.R.
 2012
 48 Supplement 6 p. 192-
1 p.
 artikel
106 112 Evaluation of Axillary Nodal Metastasis with High Resolution Magic Angle Proton Magnetic Resonance Spectroscopy in Breast Cancer Patients- a Pilot Study Kumar, S.
 2012
 48 Supplement 6 p. S73-
1 p.
 artikel
107 386 Evaluation of Crenolanib (CP-868,596) for the Treatment of FLT3-ITD-positive AML Zimmerman, E.I.
 2012
 48 Supplement 6 p. 117-118
2 p.
 artikel
108 256 Evaluation of Rare Event Detection by Flow Cytometry for Cancer Prognosis Colo, A.E.L.
 2012
 48 Supplement 6 p. S62-S63
2 p.
 artikel
109 439 Evidence for the Induction of Autophagy by AntimiR-21 Seca, H.
 2012
 48 Supplement 6 p. S106-
1 p.
 artikel
110 516 Excision of Breast Cancer Followed by Radiofrequency Ablation of Margins Decrease the Need for a Second Surgery for Close or Positive Margins Rubio, I.T.
 2012
 48 Supplement 6 p. S197-
1 p.
 artikel
111 909 Experimental Trial of Combined Chemotherapy of Intrathecal Methotrexate with Oral 6-thioguanine in Mouse Meningeal Carcinomatosis Resistant to Methotrexate Nakagawa, H.
 2012
 48 Supplement 6 p. S220-
1 p.
 artikel
112 813 Expression of Carbonic Anhydrase IX in N-diethylnitrosamine-initiated and Ferric Nitrilotriacetate-promoted Renal Cell Carcinoma Model and Effect of a Tamarind Seed Extract Olvera, C.Y. Vargas
 2012
 48 Supplement 6 p. S194-S195
2 p.
 artikel
113 400 FAK Inhibitor VS-4718 Attenuates Breast Cancer Stem Cell Function and Inhibits Tumor Growth in Vivo Xu, Q.
 2012
 48 Supplement 6 p. 122-
1 p.
 artikel
114 925 F14512, a Polyamine Vectorized Anti-cancer Drug Exhibits a Marked Antileukemic Activity, Alone and in Combination With AraC Kruczynski, A.
 2012
 48 Supplement 6 p. S223-S224
2 p.
 artikel
115 468 Forward Planning Versus Inverse Planning of Multi-lumen MammoSite Brachytherapy Mukesh, M.
 2012
 48 Supplement 6 p. S183-
1 p.
 artikel
116 540 Free Omental Flap for Partial Breast Reconstruction After Breast Conserving Surgery Zaha, H.
 2012
 48 Supplement 6 p. S203-
1 p.
 artikel
117 492 Frequency and Co-occurrence of MAPK and PI3K Pathway Driver Mutations to Guide Single-agent and Combination Therapies: an Analysis of Next Generation Sequence Data From 2700 Patients Bowden, E.T.
 2012
 48 Supplement 6 p. 152-153
2 p.
 artikel
118 755 From Genome-wide Association Studies to Translational Genomics of Bladder Cancer Prokunina-Olsson, L.
 2012
 48 Supplement 6 p. S179-
1 p.
 artikel
119 61 Functionalized and Structured Medical Wire as a Device for In-vivo Isolation of Circulating Tumor Cells in Breast Cancer Patients Nowaczyk, P.
 2012
 48 Supplement 6 p. S58-S59
2 p.
 artikel
120 222 Generation and Characterization of Novel Metastatic Variants of the Human Melanoma Cell Line Mel-Juso Mosch, B.
 2012
 48 Supplement 6 p. S54-
1 p.
 artikel
121 283 Genetic Variants in the TGF-β1 Gene and the Risk of Late Toxicity After Radiotherapy in Prostate Cancer Patients Thurner, E.M.
 2012
 48 Supplement 6 p. 87-
1 p.
 artikel
122 517 Genomic Instability is a Hallmark Feature of Serous Epithelial Ovarian Cancer and May Contribute to MicroRNA Dysregulation Kan, C.
 2012
 48 Supplement 6 p. S123-
1 p.
 artikel
123 532 Glucose-6-phosphate Dehydrogenase Inhibition and Its Effects On the Radiosensitization of Head and Neck Squamous Carcinoma Cells Hopkins, G.V.
 2012
 48 Supplement 6 p. 164-
1 p.
 artikel
124 1101 Human Tumor Cells Inhibit T Cell Responses Through Expression of Carcinoembryonic-antigen-related Cell Adhesion Molecule-6 (CEACAM-6) Khandelwal, N.
 2012
 48 Supplement 6 p. S265-
1 p.
 artikel
125 458 Hypoxia-inducible Factor 1a (HIF-1a) Induces Epithelial-mesenchymal Transition (EMT) in Thyroid Cancer Cell Lines Koh, Y.
 2012
 48 Supplement 6 p. 142-
1 p.
 artikel
126 847 Identification of a Biomarker Signature to Predict the Need for Chemotherapy in Patients With Hormone Receptor Positive Breast Cancer Korf, U.
 2012
 48 Supplement 6 p. S203-S204
2 p.
 artikel
127 96 Identification of EMTed Carcinoma and Potential Therapeutic Strategies Thiery, J.
 2012
 48 Supplement 6 p. S23-
1 p.
 artikel
128 172 Identification of Small Molecule Inhibitors of Wnt Secretion Ke, Z.
 2012
 48 Supplement 6 p. 52-53
2 p.
 artikel
129 392 Id1-induced IGF2 Promotes Tumor Angiogenesis by Paracrine Activation of Stromal Fibroblasts Cheung, A.
 2012
 48 Supplement 6 p. S95-
1 p.
 artikel
130 7 Immunotherapy of High Risk HPV Infections Melief, C.J.M.
 2012
 48 Supplement 6 p. S2-
1 p.
 artikel
131 606 Impact of Beta-blocker Medication in Patients with Platinum Sensitive Recurrent Ovarian Cancer – a Combined Analysis of 2 Prospective Multicenter Trials by the AGO Study Group, NCIC-CTG and EORTC-CTG Heitz, F.
 2012
 48 Supplement 6 p. 186-187
2 p.
 artikel
132 6 Impact of Neoadjuvant Systemic Treatment and Prior Surgery On Sentinel Lymph Node Detection – Results From the Prospective German Multiinstitutional SENTINa Trial Kühn, T.
 2012
 48 Supplement 6 p. S42-
1 p.
 artikel
133 Index of presenting authors 2012
 48 Supplement 6 p. S289-S294
6 p.
 artikel
134 436 Inflammatory Breast Cancer, Moroccan Study Errihani, H.
 2012
 48 Supplement 6 p. S174-
1 p.
 artikel
135 548 Inhibition of Glioblastoma Cells Proliferation by Fenretinide Goes Through STAT3 Pathway Campani, A. Gasperi
 2012
 48 Supplement 6 p. 168-169
2 p.
 artikel
136 249 Innate and adaptive immunity regulated within the tumor microenvironment Gajewski, T.
 2012
 48 Supplement 6 p. 76-77
2 p.
 artikel
137 235 Integrating Cancer Networks and the Value of Compute Spaces Friend, S.
 2012
 48 Supplement 6 p. 73-
1 p.
 artikel
138 301 Interleukin-6 Expression and JAK-STat Signalling in Prostate Cancer Stem Cells Kroon, P.
 2012
 48 Supplement 6 p. S74-
1 p.
 artikel
139 83 Investigation of Post-translational Modifications of c-FLIP Riley, J.S.
 2012
 48 Supplement 6 p. 27-
1 p.
 artikel
140 162 Investigation of TLR7/8 and 9 Agonists and CD40-ligand Costimulation on EBV Transformation of B Cells of Chronic Lymphocytic Leukemia Younesi, V.
 2012
 48 Supplement 6 p. S39-
1 p.
 artikel
141 485 Is Pre-treatment CT Scan Helpful in the Boost Delineation for Patients Treated with Neoadjuvant Treatment in Breast Carcinomas? Breton-Callu, C.
 2012
 48 Supplement 6 p. S188-
1 p.
 artikel
142 320 Ki67 Proliferation Index in Invasive Lobular Carcinoma of the Breast – Clinicopathologic Correlation and Prognostic Significance Wong, H.
 2012
 48 Supplement 6 p. S136-
1 p.
 artikel
143 20 Local Treatment Kunkler, I.
 2012
 48 Supplement 6 p. S46-
1 p.
 artikel
144 373 Loss of BRCA1-interacting Helicase BRIP1 Leads to Abnormal Mammary Acinar Morphogenesis – Implications for Breast Tumorigenesis Daino, K.
 2012
 48 Supplement 6 p. S90-
1 p.
 artikel
145 83 Mass Spectrometric Strategies for Protein Biomarker Discovery and Validation Aebersold, R.
 2012
 48 Supplement 6 p. S20-
1 p.
 artikel
146 280 Mechanisms of Tumor Targeting with Etirinotecan Pegol (NKTR-102): the Impact of Polymer Conjugation On Tumor Accumulation Fry, D.
 2012
 48 Supplement 6 p. 86-
1 p.
 artikel
147 186 Mechanistic Differences Between a New Platinum(II) Monosulphonamide and Cisplatin in Melanoma Cell Lines Agudo-López, A.
 2012
 48 Supplement 6 p. 56-
1 p.
 artikel
148 42 MEDI5117 Administration Confers Specific Inhibitions of IL-6 Related Growth Pathways in Tumor Xenograft Models Huang, J.
 2012
 48 Supplement 6 p. 15-
1 p.
 artikel
149 21 Meet the ERC Heldin, C.
 2012
 48 Supplement 6 p. S5-
1 p.
 artikel
150 461 MEK and SRC Inhibitors as a Combinatorial Approach to Melanoma Therapy Ferguson, J.
 2012
 48 Supplement 6 p. S110-S111
2 p.
 artikel
151 243 Meta Analysis to Compare Overall Survival Between Primary Metastatic Breast Cancer and Recurrent Metastatic Breast Cancer Aseyev, O.
 2012
 48 Supplement 6 p. S113-
1 p.
 artikel
152 564 MiRNA Expression Patterns of Colorectal Adenocarcinomas Gombos, K.
 2012
 48 Supplement 6 p. S134-
1 p.
 artikel
153 547 MiRNA Regulation of FOXL2 Expression in Juvenile-type Granulosa Cell Tumours of the Ovary Rosario, R.
 2012
 48 Supplement 6 p. S129-S130
2 p.
 artikel
154 886 Mitotic Arrest Deficiency Protein 2 (MAD2) and Histone Deacetylase 6 (HDAC6) Present a Complex Relationship in Their Regulation and Expression and Subsequent Impact on Chemoresponsiveness Weiner-Gorzel, K.
 2012
 48 Supplement 6 p. S214-
1 p.
 artikel
155 663 Modulation of AP-1, NF-κB and STAT Transcription Factors by Methoxylated Thiostilbene Derivatives in Human Squamous Carcinoma A431 Cell Line Cichocki, M.
 2012
 48 Supplement 6 p. S157-
1 p.
 artikel
156 965 Modulation of Autophagic Flux by CPTH6, a Gcn5/pCAF Histone Acetyltransferase Inhibitor With Antitumoral Activity Trisciuoglio, D.
 2012
 48 Supplement 6 p. S232-
1 p.
 artikel
157 1110 Modulation of Genistein- and Resveratrol-induced Apoptosis and Cell Proliferation in Colon Cancer Cells Brasoveanu, L.I.
 2012
 48 Supplement 6 p. S267-S268
2 p.
 artikel
158 204 Modulation of Tumour Cell Migration by Inhibition of Polysialic Acid Biosynthesis Springett, B.R.
 2012
 48 Supplement 6 p. 61-62
2 p.
 artikel
159 1165 Molecular Diagnosis of Mutations in RB1 Gene in Retinoblastoma Patients and Their Relatives – Implications for Genetic Counseling Pereira Sena, P.
 2012
 48 Supplement 6 p. S280-
1 p.
 artikel
160 86 Molecular Diagnostics in Breast Cancer – Getting Beyond ER, PR, HER2 and Proliferation Reis-Filho, J.
 2012
 48 Supplement 6 p. S21-
1 p.
 artikel
161 662 Molecular Mechanisms in Interleukin-6-induced Vascular Endothelial Growth Factor-C Expression in Lymphatic Endothelial Cells Huang, Y.H.
 2012
 48 Supplement 6 p. S157-
1 p.
 artikel
162 324 Monoclonal Antibodies Against Novel Tumor Markers for Diagnostic Prognostic and Predictive Applications Grifantini, R.
 2012
 48 Supplement 6 p. 99-
1 p.
 artikel
163 107 Multi-level Gene Expression Regulation Effects of the NAMPT Inhibitor FK866 in a Model of Acute T Cell Leukemia Zucal, C.
 2012
 48 Supplement 6 p. 33-34
2 p.
 artikel
164 861 Nanofluidic Digital PCR Quantitation of Multiple KRAS Mutations in Colorectal and Pancreatic Carcinoma Ginesta, M.
 2012
 48 Supplement 6 p. S207-S208
2 p.
 artikel
165 426 Neoadjuvant Endocrine Therapy: Retrospective Analysis of Some Mechanisms of Resistance Semiglazov, V.F.
 2012
 48 Supplement 6 p. S171-
1 p.
 artikel
166 184 Neurotensin-polyplex as a Potential Tool in Gene Therapy for Human Breast Cancer Castillo-Rodriguez, R.
 2012
 48 Supplement 6 p. S93-
1 p.
 artikel
167 131 N-linked Glycosylation Regulates the Function and Membrane Localization of KCC4 Weng, T.
 2012
 48 Supplement 6 p. S31-
1 p.
 artikel
168 517 NMS-P153, a Tight-Binder Inhibitor of the Spindle Assembly Checkpoint Kinase MPS1 Colombo, R.
 2012
 48 Supplement 6 p. 159-
1 p.
 artikel
169 799 Novel High-sensitive D-dimer Determination Predicts Chemotherapy-associated Venous Thromboembolism in Cancer Patients Ferroni, P.
 2012
 48 Supplement 6 p. S190-
1 p.
 artikel
170 NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality Stupp, Roger
 2012
 48 Supplement 6 p. 2192-2202
11 p.
 artikel
171 150 Optimal Age to Start Preventive Measures in Women with BRCA1/2 Mutations or High Familial Breast Cancer Risk Tilanus-Linthorst, M.M.A.
 2012
 48 Supplement 6 p. S83-S84
2 p.
 artikel
172 513 Outcome of Breast Conserving Therapy Via Reduction Mammoplasty in Breast Cancer Patients Gulcelik, M.A.
 2012
 48 Supplement 6 p. S196-
1 p.
 artikel
173 195 Overexpression of Integrin αvβ3 in Human Laryngel Carcinoma (Hep2) and Tongue Squamous Carcinoma (Cal27) Cells: Adhesion, Migration, Invasion and Resistance to Antitumor Drugs Stojanovic, N.
 2012
 48 Supplement 6 p. S48-
1 p.
 artikel
174 579 Parthenolide Inhibits Tumor Promotion – Epigenetic Regulation of P21 Darwiche, N.
 2012
 48 Supplement 6 p. S138-
1 p.
 artikel
175 482 Patient Preferences for Adjuvant Radiotherapy in Early Breast Cancer – an Australian Sub-study of the International TARGIT Trial Corica, T.
 2012
 48 Supplement 6 p. S187-
1 p.
 artikel
176 PG 4.02 Pancreatic surgery: Beyond the traditional limits Schmied, B.
 2012
 48 Supplement 6 p. S3-S4
2 p.
 artikel
177 PG 2.04 Systemic treatment of CRC: Molecular profiles ready for clinical practice? Tejpar, S.
 2012
 48 Supplement 6 p. S3-
1 p.
 artikel
178 PG 8.01 Writing and submitting an outstanding scientific manuscript Haller, D.G.
 2012
 48 Supplement 6 p. S8-S9
2 p.
 artikel
179 579 Phase I and Pharmacokinetic (PK) Study of Pazopanib in Combination with Two Schedules of Docetaxel (D) in Patients (pts) with Advanced Solid Tumors Hamberg, P.
 2012
 48 Supplement 6 p. 177-
1 p.
 artikel
180 Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer Schønnemann, K.R.
 2012
 48 Supplement 6 p. 510-517
8 p.
 artikel
181 Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma – A report from the Société Française des Cancers et leucémies de l’Enfant et de l’adolescent (SFCE) Minard-Colin, Véronique
 2012
 48 Supplement 6 p. 2409-2416
8 p.
 artikel
182 Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma Geoerger, Birgit
 2012
 48 Supplement 6 p. 253-262
10 p.
 artikel
183 752 Phytotherapy with Angiosperms From Arid Zones of Northern Mexico in Patients With Malignant and Benign Tumors Lópéz-Moreno, C.
 2012
 48 Supplement 6 p. S178-
1 p.
 artikel
184 1044 PI3K Inhibition Sensitizes Patient-derived Tumor Graft Models of Triple Negative Breast Cancer to PARP Inhibition Ibrahim, Y.
 2012
 48 Supplement 6 p. S251-S252
2 p.
 artikel
185 356 Plexin B1 Trafficking in Prostate Cancer Legendre, A.
 2012
 48 Supplement 6 p. S86-S87
2 p.
 artikel
186 1068 Potent, Cellular Inhibitors of Glucose-6-phosphate Dehydrogenase – Potential for Novel Therapeutic Intervention in Cancer James, D.
 2012
 48 Supplement 6 p. S258-
1 p.
 artikel
187 495 P72R and PIN3 TP53 Polymorphisms and Colorectal Cancer Risk Oliveira, L.P.
 2012
 48 Supplement 6 p. S119-
1 p.
 artikel
188 372 Preclinical Characterization of RG7256, a Potent and Selective BRAF Inhibitor with Differentiation From Vemurafenib Su, F.
 2012
 48 Supplement 6 p. 114-
1 p.
 artikel
189 520 Promoter Hypermethylation of HIST1H4K and RASSF2 in Urine From Prostate Cancer Patients Kachakova, D.
 2012
 48 Supplement 6 p. S123-S124
2 p.
 artikel
190 441 Quality Assurance of Biomarker Assays in Clinical Trials Hall, J.A.
 2012
 48 Supplement 6 p. 137-
1 p.
 artikel
191 361 Quality of Life of Breast Cancer Patients Medicated with Anti-estrogens, 2 Years After Acupuncture Treatment: a Qualitative Study Hervik, J.
 2012
 48 Supplement 6 p. S148-
1 p.
 artikel
192 271 Quantitative Analysis of RORalpha mRNA Expression in Human Breast Cancer Odawara, H.O.
 2012
 48 Supplement 6 p. S121-S122
2 p.
 artikel
193 395 Radiation Induced Skin Toxicity Following Hypofractionated Radiotherapy Treatment in Early Breast Cancer: Single Institution Experience Fragandrea, I.
 2012
 48 Supplement 6 p. S158-
1 p.
 artikel
194 215 Radiotherapy in Relation to Biology Chua, B.H.
 2012
 48 Supplement 6 p. S105-S106
2 p.
 artikel
195 Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer Fizazi, K.
 2012
 48 Supplement 6 p. 85-93
9 p.
 artikel
196 3 Randomized Discontinuation Designs in Early Clinical Drug Screening – how to Adapt if the Drug Works too well? The Cabozantinib Experience Weitzman, R.
 2012
 48 Supplement 6 p. 3-
1 p.
 artikel
197 80 Rational Targeting of Inhibitor of Apoptosis Proteins (IAPs) for Effective Therapy of Malignant Pleural Mesothelioma Crawford, N.
 2012
 48 Supplement 6 p. 26-
1 p.
 artikel
198 296 Regulator of G Protein Signaling 6 (RGS6) Suppresses Mammary Tumorigenesis by Enhancing DNA Damage Signaling and Blocking Oncogenic Transformation Maity, B.
 2012
 48 Supplement 6 p. S128-
1 p.
 artikel
199 571 Results and Complications of Autologous Latissimus Dorsi Flap Breast Reconstruction Fakhry, H.
 2012
 48 Supplement 6 p. S211-S212
2 p.
 artikel
200 637 Role of HEY1 in Osteosarcoma Metastasis Setoguchi, T.
 2012
 48 Supplement 6 p. S151-
1 p.
 artikel
201 253 Role of NANOS Family Members in Tumor Progression Andries, V.
 2012
 48 Supplement 6 p. S62-
1 p.
 artikel
202 1126 Role of Polymorphisms in the ERCC2 Gene in the Development of Severe Side Effects After Radiotherapy of Prostate Cancer Patients Thurner, E.M.
 2012
 48 Supplement 6 p. S271-
1 p.
 artikel
203 1058 S100A4 Acts Synergistically With VEGF in Promoting Angiogenesis and a Neutralizing Monoclonal Antibody Against S100A4 Could Be a Novel Strategy to Combat Solid Tumors Hernandez, J.
 2012
 48 Supplement 6 p. S256-
1 p.
 artikel
204 1062 Selection for Trabectedin Resistance Induces Stable and p53-independent Hypersensitivity Against Cisplatin in Human Colon Cancer Cells Englinger, B.
 2012
 48 Supplement 6 p. S256-S257
2 p.
 artikel
205 602 Sentinel Lymph Node Micrometastases. How to Act? Sanz, M.C.
 2012
 48 Supplement 6 p. S220-S221
2 p.
 artikel
206 Sham-controlled, randomised, feasibility trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma Meng, Zhiqiang
 2012
 48 Supplement 6 p. 1692-1699
8 p.
 artikel
207 284 Slug Controls P-cadherin and Regulates Stem/progenitor Cell Dynamics During Mammary Gland Morphogenesis Idoux-Gillet, Y.
 2012
 48 Supplement 6 p. S69-S70
2 p.
 artikel
208 Societies' Profiles 2012
 48 Supplement 6 p. ix-x
nvt p.
 artikel
209 155 Sorafenib Synergizes with the Antidiabetic Drug Metformin in Non-Small Cell Lung Cancer (NSCLC) Groenendijk, F.H.
 2012
 48 Supplement 6 p. 48-
1 p.
 artikel
210 198 Specific Adverse Events Predict Survival Benefit in Early Breast Cancer Patients Treated with Exemestane in the Dutch/Belgian TEAM Trial Fontein, D.
 2012
 48 Supplement 6 p. S101-
1 p.
 artikel
211 Specific-site methylation of tumour suppressor ANKRD11 in breast cancer Lim, Sue Ping
 2012
 48 Supplement 6 p. 3300-3309
10 p.
 artikel
212 306 Subtype-specific Models of Pancreatic Ductal Adenocarcinoma Reveal Signaling Pathways That Can Be Exploited Therapeutically Eisen, C.
 2012
 48 Supplement 6 p. S75-
1 p.
 artikel
213 200 Suppression of Tumor Growth and Metastasis by Anti-Podoplanin Antibodies Kunita, A.
 2012
 48 Supplement 6 p. 60-61
2 p.
 artikel
214 Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United Kingdom Lightfoot, T.J.
 2012
 48 Supplement 6 p. 263-269
7 p.
 artikel
215 Susan G. Komen for the Cure® 2012
 48 Supplement 6 p. xviii-
1 p.
 artikel
216 992 Targeting ErbB2 (neu) Using Transmembrane Peptides is a Promising Novel Therapeutic Strategy for Breast Cancer Arpel, A.
 2012
 48 Supplement 6 p. S239-
1 p.
 artikel
217 413 Targeting HdmX as a Therapeutic Approach for Cancer Wald, D.
 2012
 48 Supplement 6 p. 125-126
2 p.
 artikel
218 565 Targeting P38δ MAPK in Oesophageal Cancer: a Possible Future Therapeutic Goal? O'Callaghan, C.
 2012
 48 Supplement 6 p. 173-174
2 p.
 artikel
219 252 TAS-2104, a Highly Potent and Selective Aurora A Inhibitor, Enhanced Antitumor Activity of Taxanes in Vivo Ishihara, K.
 2012
 48 Supplement 6 p. 77-
1 p.
 artikel
220 218 TC-NER Dependent Degradation of RNA Pol II in Response to Lurbinectedin (PM01183) Santamaría, G.
 2012
 48 Supplement 6 p. 66-
1 p.
 artikel
221 1023 The Application of Novel Iron Chelators in Cancer Treatment Serda, M.
 2012
 48 Supplement 6 p. S247-
1 p.
 artikel
222 126 The Beliefs, Knowledge, Understanding, Attitudes and Treatment Access to Breast Cancer Amongst Rural Women in Northern Nigeria Odiase, E.
 2012
 48 Supplement 6 p. S77-
1 p.
 artikel
223 666 The Biological Connection Markup Language – a Data Format to Visualize, Annotate and Analyze Biological Pathways Beltrame, L.
 2012
 48 Supplement 6 p. S158-
1 p.
 artikel
224 239 The Cancer-associated K351N Mutation Affects the Ubiquitination and the Translocation to Mitochondria of p53 Protein Tuosto, L.
 2012
 48 Supplement 6 p. S58-
1 p.
 artikel
225 69 The ceRNA Hypothesis and the Non-coding Revolution in Cancer Research and Therapy Pandolfi, P.
 2012
 48 Supplement 6 p. S16-S17
2 p.
 artikel
226 17 The Challenges of Drug Combination Studies De Bono, J.
 2012
 48 Supplement 6 p. 9-
1 p.
 artikel
227 844 The Changes in MGMT Promoter Methylation Status in Primary and Recurrent Glioblastomas Park, C.
 2012
 48 Supplement 6 p. S203-
1 p.
 artikel
228 167 The Clinical Features and Prognosis of Tubular Breast Cancer Izquierdo, M.
 2012
 48 Supplement 6 p. S88-S89
2 p.
 artikel
229 38 The COGS (Collaborative Oncological Gene-environment Study): Progress and Results Easton, D.F.
 2012
 48 Supplement 6 p. S9-
1 p.
 artikel
230 128 The Effect of a Novel Daunomycin-conjugate With an ErbB2 Receptor-binding Peptide on the Protein Expression Profile of HL-50 Cells Orban, E.
 2012
 48 Supplement 6 p. S31-
1 p.
 artikel
231 596 The Effect of Rifampin On the Pharmacokinetics of Tivozanib, a Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor Cotreau, M.
 2012
 48 Supplement 6 p. 183-
1 p.
 artikel
232 4 The Genomic Landscapes of Breast Cancer and Their Clinical Relevance Caldas, C.
 2012
 48 Supplement 6 p. S2-
1 p.
 artikel
233 35 The Genomics of Drug Sensitivity in Cancer Stratton, M.
 2012
 48 Supplement 6 p. S8-
1 p.
 artikel
234 338 The HER2 Amplicon Includes Several Genes Required for the Growth and Survival of HER2 Positive Breast Cancer Cells Hongisto, V.
 2012
 48 Supplement 6 p. S82-S83
2 p.
 artikel
235 347 The Impact of Chemotherapeutic Regimens On the Cost-utility Analysis of Oncotype DX Assay Madaras, B.
 2012
 48 Supplement 6 p. S144-
1 p.
 artikel
236 479 The Impact of EGF on Notch Protein Levels in Non-Small Cell Lung Cancer Giannopoulou, E.
 2012
 48 Supplement 6 p. S115-
1 p.
 artikel
237 306 The Influence of Education Level On the Survival of Breast Cancer Hwang, K.T.
 2012
 48 Supplement 6 p. S131-S132
2 p.
 artikel
238 225 The Long Non-coding RNA ANRIL is a Direct Transcriptional Target of E2F1 That Mediates E2F1-induced Proliferation Bashari, D.
 2012
 48 Supplement 6 p. S55-
1 p.
 artikel
239 138 The MDM2 Inhibitor Nutlin-3 But Not the p53 Activator RITA Induces Loss-of-function p53 Mutations Michaelis, M.
 2012
 48 Supplement 6 p. 43-
1 p.
 artikel
240 889 The Methylation Pattern of Pancreatic Juice Offers Good Diagnostic Yield in the Diagnosis of Pancreatic Carcinomas Diagnostic Ginesta, M.
 2012
 48 Supplement 6 p. S215-
1 p.
 artikel
241 427 The mitochondrial basis of resistance to BCL-2 antagonists and conventional chemotherapy Letai, A.
 2012
 48 Supplement 6 p. 133-
1 p.
 artikel
242 207 Theories of Cellular Ageing and the Influence of Technology Ruiz-Gomez, M.J.
 2012
 48 Supplement 6 p. S50-
1 p.
 artikel
243 33 The Patient Perspective – Influencing the Doctors of Tomorrow Marven, M.
 2012
 48 Supplement 6 p. S50-
1 p.
 artikel
244 229 The Prognosis and the Validity of Early Detection of Bone Recurrence After Breast Cancer Surgery Koyma, Y.
 2012
 48 Supplement 6 p. S109-
1 p.
 artikel
245 159 The Role of the Biophysical Properties of the Glycocalyx and Extracellular Matrix Tension in Enhancing Glioma Cell Invasion Miroshnikova, Y.A.
 2012
 48 Supplement 6 p. S38-S39
2 p.
 artikel
246 378 The Support and Information Needs of Women with Advanced Breast Cancer Marven, M.
 2012
 48 Supplement 6 p. S153-
1 p.
 artikel
247 871 The Use of Automated Image-cytometry for Improved Non-invasive Bladder Cancer Detection by Multiprobe FISH Assay Pajor, G.
 2012
 48 Supplement 6 p. S210-
1 p.
 artikel
248 52 The use of Metabolomics to Discover Novel Metabolic Networks and new Targets for Cancer Treatment Gottlieb, E.
 2012
 48 Supplement 6 p. S13-
1 p.
 artikel
249 322 The VEGF-a Splice Variants VEGF155 and VEGF155b Differentially Control the Proliferation of Non Small Cell Lung Carcinoma Cells Eymin, B.
 2012
 48 Supplement 6 p. S79-
1 p.
 artikel
250 411 Three-Dimensional Co-culture of Mesenchymal Stem Cells With Colorectal Cancer Cells in Vitro Has a Distinct Effect on Cytokine Secretion Hogan, N.
 2012
 48 Supplement 6 p. S99-
1 p.
 artikel
251 Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis Monk, Bradley J.
 2012
 48 Supplement 6 p. 2361-2368
8 p.
 artikel
252 302 Transcriptional Cooperation Between p53 and Estrogen Receptors in a Breast Cancer Model Lion, M.
 2012
 48 Supplement 6 p. S74-
1 p.
 artikel
253 66 Trifluorothymidine Incorporation into DNA is the Primary Mechanism of Action of TAS-102, and Leads to Markedly Prolonged Survival in a Mouse Model Tanaka, N.
 2012
 48 Supplement 6 p. 22-
1 p.
 artikel
254 47 Triple Negative Breast Cancer – Experience of a Single Tertiary Center Allameddine, R.
 2012
 48 Supplement 6 p. S54-
1 p.
 artikel
255 503 TRPV4 Channels in Basal-like Breast Cancer Cells Jamaludin, S.Y.N.
 2012
 48 Supplement 6 p. 155-156
2 p.
 artikel
256 718 Tumor Suppressors and Tissue Specificity in Cancer – the Role of Rad51c in Sebaceous and Mammary Carcinomas Tumiati, M.
 2012
 48 Supplement 6 p. S170-
1 p.
 artikel
257 121 Tumor-targeted Nanobullets for Anti-cancer Combination Therapy van der Meel, R.
 2012
 48 Supplement 6 p. 38-
1 p.
 artikel
258 145 Tumour Protein D52 – a Survival Factor in ERBB2-overexpressing Breast Cancer Cells Roslan, N.
 2012
 48 Supplement 6 p. S35-
1 p.
 artikel
259 945 Ultraviolet C Radiation Increases the DNA Degradation Induced by Methyl Methane Sulphonate Ruiz-Gomez, M.J.
 2012
 48 Supplement 6 p. S227-
1 p.
 artikel
260 451 Underestimation Rate of Invasive Malignancy in Atypical Lobular Hyperplasia (ALH) and Lobular in Situ Carcinoma (LCIS) Guyon, L.
 2012
 48 Supplement 6 p. S178-
1 p.
 artikel
261 599 Up-regulation of ER-b, p53 and p21 Sensitizes Tamoxifen Resistant Breast Cancer Cells to Tamoxifen Pitta, C.A.
 2012
 48 Supplement 6 p. S142-S143
2 p.
 artikel
262 270 Using Engineered Antibodies to Study the Limitations of Immunomagnetic Isolation of Tumor Cells Jain, J.
 2012
 48 Supplement 6 p. S66-
1 p.
 artikel
263 6 Using Whole Genome Sequencing for Digital Analysis of Tumour Evolution Mardis, E.
 2012
 48 Supplement 6 p. S2-
1 p.
 artikel
264 530 When Mastectomy is Needed – is the Nipple Sparing Procedure a New Standard with Very Few Contraindications? Fortunato, L.
 2012
 48 Supplement 6 p. S201-
1 p.
 artikel
265 588 Why Some Surgeons Omit Sentinel Node Biopsy in Breast Cancer Patients? Barriers to Popularize Sentinel Node Biopsy in Low Resource Areas Alavi, N.
 2012
 48 Supplement 6 p. S216-
1 p.
 artikel
                             265 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland